Vesiculobullous Darier Disease Symptomatically Responsive to Cetirizine
Journal
Journal of drugs in dermatology : JDD
ISSN: 1545-9616
Titre abrégé: J Drugs Dermatol
Pays: United States
ID NLM: 101160020
Informations de publication
Date de publication:
01 Feb 2019
01 Feb 2019
Historique:
entrez:
28
2
2019
pubmed:
28
2
2019
medline:
7
6
2019
Statut:
ppublish
Résumé
Darier disease is an autosomal dominant genodermatosis of abnormal keratinization characterized by hyperkeratotic papules and plaques with a predilection for seborrheic areas. We report a case of a rare vesiculobullous variant of treatment-resistant Darier disease in a 55-year-old woman that failed topical tacrolimus and topical and oral glucocorticoids. Cetirizine was initiated at 10 mg daily and increased to 40 mg daily over four weeks, with resultant marked improvement of the patient’s burning sensation. A punch biopsy revealed a perivascular infiltrate of eosinophils. This patient’s symptomatic improvement with cetirizine, which has antagonizing properties against eosinophils, highlights the potential role of eosinophils in the pathogenesis of vesiculobullous Darier disease. We suggest that major basic protein secreted by eosinophils may propagate blister formation in vesiculobullous Darier disease by disrupting desmosomes.
J Drugs Dermatol. 2019;18(2):213-214.
Substances chimiques
Anti-Allergic Agents
0
Cetirizine
YO7261ME24
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM